Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOptimi Health Corp. Common Shares

Optimi Health Corp. Common Shares

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
2.34 USD -0.05 ( 2.09%)
Last update at 2026-11-06T21:00:00Z
VOLUME
18327
Market Cap
29.03M

Momentum Score

…

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.25
Low
2.41
High
52 Week Price Range
4.00
Low
8.84
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Optimi Health Corp (NASDAQ: OPTH) is limited and the company is listed in the healthcare sector. Long-term growth drivers may include advancement of its development pipeline, successful commercialization of any approved products and strategic partnerships or licensing deals that extend market access. Investors may find upside if the company achieves product approvals and secures financing to scale operations.

Key investment risks are financing and cash‑runway uncertainty, absence of recurring revenue or profitability, regulatory or clinical setbacks and low public float that can increase share-price volatility.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.39
Dividend Yield
-
Revenue TTM
0.18M
Revenue Per Share
0.05
Gross Profit TTM
-0.31M
Debt / Equity
1.02
ROE
-54.36%
Net Debt
5.55M
ROCE
-47.26%
Diluted EPS TTM
-1.56

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -3.72M -6.04M -5.19M -7.35M -6.02M
Net income -3.72M -6.04M -5.19M -7.35M -6.02M
Selling general administrative 2.69M 3.63M 3.56M 4.03M 2.98M
Selling and marketing expenses 0.03M 0.36M 0.37M 2.11M 2.08M
Gross profit -2.08M 0.27M -0.16M 0.05M -0.05M
Reconciled depreciation 0.95M 0.87M 0.73M 0.29M -
Ebit -3.18M -5.61M -5.15M -7.32M -6.00M
Ebitda -2.23M -4.74M -4.42M -7.03M -5.95M
Depreciation and amortization 0.95M 0.87M 0.73M 0.29M 0.05M
Operating income -4.53M -5.61M -4.38M -7.39M -6.06M
Other operating expenses 4.96M 6.00M 4.56M 7.47M 6.06M
Interest expense 0.53M 0.43M 0.04M 0.03M 0.02M
Interest income 0.01M 0.00M 0.14M 0.07M -
Net interest income -0.52M -0.43M 0.09M 0.04M -
Total revenue 0.43M 0.39M 0.18M 0.08M -
Total operating expenses 2.46M 5.88M 4.22M 7.44M 6.06M
Cost of revenue 2.50M 0.12M 0.34M 0.03M 0.05M
Total other income expense net 0.82M -0.43M -0.81M 0.04M 0.04M
Net income from continuing ops -3.71M -6.04M -5.19M -7.35M -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 15.23M 14.55M 16.49M 16.82M 23.46M
Other current assets 0.28M 0.11M 0.14M 0.18M 1.56M
Total liab 8.65M 4.98M 3.28M 0.80M 2.40M
Total stockholder equity 6.58M 9.58M 13.21M 16.02M 21.07M
Other current liab 0.70M 1.36M 0.56M 0.64M 0.04M
Common stock 31.74M 31.16M 28.70M 26.61M 25.16M
Capital stock 31.69M 31.16M 28.70M 26.61M -
Retained earnings -27.28M -23.61M -17.65M -13.43M -6.19M
Other assets - 0.00M - -0.01M -
Cash 1.14M 0.10M 1.34M 1.89M 8.43M
Total current liabilities 8.50M 3.22M 1.61M 0.73M 2.24M
Current deferred revenue 0.21M 0.12M 0.11M -0.56M -
Net debt 5.55M 2.65M 0.36M -1.73M -8.18M
Short term debt 6.40M 0.99M 0.04M 0.09M 0.10M
Short long term debt 6.33M 0.96M - - -
Short long term debt total 6.69M 2.75M 1.71M 0.16M 0.25M
Total current assets 1.83M 1.23M 2.43M 2.43M 14.30M
Short term investments 0.01M - - 0.00M 4.00M
Net receivables 0.10M 0.12M 0.17M 0.10M 0.19M
Long term debt - 1.76M 1.64M - -
Inventory 0.31M 0.89M 0.78M 0.26M 0.12M
Accounts payable 1.19M 0.75M 0.90M 0.56M 2.11M
Accumulated other comprehensive income 2.12M 2.03M 2.16M 2.83M 2.10M
Non currrent assets other 0.83M 0.02M 0.02M 0.01M 0.26M
Non current assets total 13.41M 13.32M 14.06M 14.40M 9.16M
Capital lease obligations 0.18M 0.03M 0.07M 0.16M -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - - 0.00M 4.00M -
Total cashflows from investing activities -0.09M -0.15M -0.71M -3.15M -9.19M
Net borrowings 3.40M 0.96M 1.92M -0.11M -
Total cash from financing activities 3.76M 3.19M 3.76M 1.19M 19.18M
Net income -3.71M -6.04M -5.19M -7.35M -6.02M
Change in cash 1.04M -1.24M -0.54M -6.54M 3.96M
Begin period cash flow 0.10M 1.34M 1.89M 8.43M 4.47M
End period cash flow 1.15M 0.10M 1.34M 1.89M 8.43M
Total cash from operating activities -2.63M -4.28M -3.60M -4.58M -6.02M
Issuance of capital stock 0.40M 2.04M 1.84M 0.00M -
Depreciation 0.95M 0.87M 0.73M 0.29M 0.05M
Other cashflows from investing activities - -0.00M 0.10M -6.25M -0.26M
Change to inventory 0.50M 0.02M -0.21M -0.26M -
Change to account receivables 0.03M 0.04M -0.07M 0.09M -0.10M
Other cashflows from financing activities -0.04M 0.20M -0.06M 1.30M 0.36M
Capital expenditures 0.09M 0.15M 0.80M 7.15M 4.94M
Change in working capital 1.25M 0.76M 0.83M 1.45M -1.49M
Stock based compensation 0.05M 0.06M 0.16M 1.01M 1.26M
Other non cash items -1.16M 0.07M -0.13M 0.02M 0.18M
Free cash flow -2.72M -4.43M -4.41M -11.73M -10.96M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
OPTH
Optimi Health Corp. Common Shares		 -0.05
2.09%		 2.34 - - 165.25 2.14 169.99
MKKGY
Merck KGaA ADR		 -0.22
0.66%		 33.17 21.25 14.93 3.10 2.14 3.60
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.17
0.80%		 21.02 - 10.96 0.01 1.20 2.94
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.85 - 10.66 0.01 1.16 2.94

Profile*

Optimi Health Corp. Common Shares

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

269 David Brown Way, Princeton, BC, Canada, V0X 1W0

778-761-4551

https://www.optimihealth.ca

6

Name Title Year Born
Mr. John James Wilson Co-Founder & Chairman 1989
Mr. Dane Stevens Co-Founder, CEO, Chief Marketing Officer & Director 1989
Mr. Bryan Edward Safarik Co-Founder, COO & Director 1985
Mr. Jacob Safarik Interim CFO & Director 1988
Dr. Preston A. Chase Chief Science Officer NA
Ms. Ann Little Human Resources Manager NA
Ms. Leah Hodges Corporate Secretary 1984

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…